Editor's Note According to a new study from the University of Michigan, a surge in multiple respiratory viruses was associated with different pediatric acute care across emergency departments (EDs) across the state. The findings appeared in JAMA Network Open on December 7. The study used data from more than 2.7…

Read More

Editor’s note Moderna’s mRNA-based RSV vaccine is effective in preventing RSV-associated lower-respiratory tract disease in adults aged 60 an older, according to randomized phase II-III trial results published December 14 in The New England Journal of Medicine. Results also confirmed the safety of a single dose of the vaccine, researchers…

Read More

Editor's Note Hospitals in Fresno County, California are operating over capacity by 20% to 40% due to a sharp rise in respiratory diseases such as flu, COVID-19 and RSV, according to a December 18 press release from the Fresno County Department of Public Health. In addition to straining resources, the…

Read More

Editor's Note The Centers for Disease Control and Prevention (CDC) is sounding the alarm regarding low vaccination rates for COVID-19 and flu for all adults, as well as low RSV vaccination rates for adults 60 and older. According to the December 14 announcement, study data show anti-virals are also being…

Read More

Editor's Note A new vaccine for respiratory syncytial virus (RSV) has been found to be effective against a range of variants, according to an August 2023 Science Translational Medicine research article titled, "The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains." This research was…

Read More

Editor's Note A shortage of medications used in treatment of pediatric illnesses are causing additional challenges for healthcare providers amid spikes in respiratory viruses, according to a November 22 CNN story, reports Becker’s Hospital Review November 23. It was reported by the American Society of Health-System Pharmacists (ASHP) that as…

Read More